SCHEMBL16488121

SCHEMBL16488121

OB(O)c1ccc(-c2nnc(-c3cccc4[nH]ccc34)o2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.48
▸ GAA P10253 7/20 0.44
▸ MGAM O43451 6/20 0.44
▸ SI P14410 6/20 0.44
▸ MGAM2 Q2M2H8 6/20 0.44
▸ PIK3CD O00329 3/20 0.43
▸ PIK3CB P42338 2/20 0.40
▸ PIK3CG P48736 1/20 0.39
▸ ASH1L Q9NR48 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.37
▸ RAB9A P51151 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ TP53 P04637 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12171947 0.75 ATR (0.49) ATRPIK3CDASH1LALDH1A1RAB9A
SCHEMBL12419574 0.73 NPC1 (0.52) GAAMGAMSIMGAM2ASH1L
SCHEMBL12419559 0.73 RAB9A (0.53) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL2816834 0.72 NPC1 (0.65) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL12419575 0.72 ALDH1A1 (0.44) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL29954839 0.69 HPGDS (0.54) PIK3CDPIK3CBPIK3CGASH1L
SCHEMBL12419558 0.69 STIM1 (0.39) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL12508694 0.69 SMN1; SMN2 (0.66) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL12420282 0.68 RAB9A (0.36) GAAALDH1A1RAB9AKDM4EHSD17B10
SCHEMBL12419567 0.68 PARP1 (0.37) GAAALDH1A1RAB9AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ATR 4840/4885GAA 344/4885MGAM 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback